DRREDDY IN EQUITY
loading…—
Day range—
52-week range—
Market cap—
P/E · TTM—
As of—
| CUSTOMER | BASIS | EST ₹CR | RANGE | % REV | BUCKET | PERIOD | METHOD | CONF |
|---|---|---|---|---|---|---|---|---|
| China. | UNSTATED | 29,359 | 19,181–29,359 | 90.0% | — | FY26 | EST | 75% |
| “Revenue from our Rest of the World markets (which includes Brazil, China, South Africa, Australia, and certain other markets) for FY2025 was ` 19.9 bn, represe…” AR · +1 DOC | ||||||||
| Authority. | UNSTATED | 29,359 | 19,181–29,359 | 90.0% | — | FY25 | EST | 75% |
| “Provide details of corrective action taken or underway on any issues related to anticompetitive conduct by the entity, based on adverse orders from regulatory …” AR · +1 DOC | ||||||||
| Karnataka | UNSTATED | 29,359 | 19,181–29,359 | 90.0% | — | FY26 | EST | 75% |
| “In his IAS career he has served in various field and secretariat positions in India in the Government of India, Government of Karnataka and at the World Bank.” AR DOC | ||||||||
| Australia | UNSTATED | 29,359 | 19,181–29,359 | 90.0% | — | FY25 | EST | 75% |
| “Revenue from our Rest of the World markets (which includes Brazil, China, South Africa, Australia, and certain other markets) for FY2025 was ` 19.9 bn, represe…” AR DOC | ||||||||
| Securities and Exchange Board of India | UNSTATED | 29,359 | 19,181–29,359 | 90.0% | — | FY26 | EST | 70% |
| “(Not applicable to the Company during the audit period) f) The Securities and Exchange Board of India (Registrars to an Issue and Share Transfer Agents) Regula…” AR · +1 DOC | ||||||||
| Others | UNSTATED | 29,359 | 19,181–29,359 | 90.0% | — | FY25 | EST | 70% |
| “Business Conduct: Stakeholder group from whom complaint is received Grievance redressal mechanism in place (Yes/No) (If Yes, then provide web link for grievanc…” AR · +1 DOC | ||||||||
| Financial Year | UNSTATED | 29,359 | 19,181–29,359 | 90.0% | — | FY24 | EST | 70% |
| “Job creation in smaller towns – Disclose wages paid to persons employed (including employees or workers employed on a permanent or non-permanent/on contract ba…” AR DOC | ||||||||
| Dr. Reddy's And Nestle Health Science | UNSTATED | 29,359 | 19,181–29,359 | 90.0% | — | FY25 | EST | 70% |
| “Revenue from contracts with customers: Particulars For the year ended March 31, 2025 For the year ended March 31, 2024 Sales 218,448 192,764 Service income 1,3…” AR DOC | ||||||||
| Torrent | UNSTATED | 29,359 | 19,181–29,359 | 90.0% | — | 2026-07 | EST | 65% |
| “M. V. Narasimham: So, here, as per the orders we received from India, like, Torrent and USV and whatever is as per the agreement, that's already taken care of.” CONCALL DOC | ||||||||
| FY27 | UNSTATED | 29,359 | 19,181–29,359 | 90.0% | — | FY27 | EST | 65% |
| “Subject to a successful validation, we will resume commercial supply to our long term partner, OneSource, and will be on track to supply, hopefully, 6-7 millio…” CONCALL DOC | ||||||||
| SYNGENESyngene International Ltd. | UNSTATED | 2,818 | 1,841–2,818 | 8.6% | — | FY25 | EST | 70% |
| “At Dr Reddy’s Laboratories, he established the Global Quality Management System and was also responsible for the quality oversight of all external suppliers wo…” AR DOC | ||||||||
| ACEAction Construction Equipment Ltd. | UNSTATED | 2,776 | 1,814–2,776 | 8.5% | — | FY26 | EST | 65% |
| “Brand Honchos - Global CSR & ESG Awards 2025 CSR project 'Action for Climate and Environment (ACE)' awarded under the category of 'Most Impactful Environment P…” AR DOC | ||||||||
| CDSLCentral Depository Services (India) Ltd. | UNSTATED | 5 | 3–5 | 0.0% | — | FY26 | EST | 60% |
| “The password to open the .pdf file is your 8-digit client ID for NSDL account, last 8 digits of client ID for CDSL account or folio number for shares held in p…” AR · +1 DOC | ||||||||
| BSEBSE Ltd. | UNSTATED | 0 | 0–0 | 0.0% | — | FY26 | EST | 65% |
| “Leadership category on the Indian Corporate Governance Scorecard 2025 Awarded jointly by Institutional Investor Advisory Services (liAS), the International Fin…” AR DOC | ||||||||
| Renewable Energy | UNSTATED | — | — | — | COGS | FY25 | EST | 75% |
| “Renewables as on FY2025 Renewable energy programmes • PPA - Power Purchase Agreement • Rooftop solar • ISTS-Inter-StateTransmissionSystem • Intrastaterene…” AR DOC | ||||||||
| SUPPLIER | BASIS | EST ₹CR | RANGE | % COST | BUCKET | PERIOD | METHOD | CONF |
|---|---|---|---|---|---|---|---|---|
| FORTISFortis Healthcare Ltd. | UNSTATED | 8,215 | 5,367–8,215 | 64.9% | — | FY26 | EST | 75% |
| “In the past, Mr. Puri was also holding the Board positions as an Independent Director at Tata Sons, (the holding company of the Tata group), Hindustan Unilever…” AR DOC | ||||||||
| NEULANDLABNeuland Laboratories Ltd. | UNSTATED | 1,821 | 1,190–1,821 | 14.4% | — | FY26 | EST | 75% |
| “He has also served on various Boards as Independent Director - Axis Bank, SKF India, Dr. Reddy’s Laboratories, Sanmar Group, Singapore Tourism Board, Grantham …” AR · +1 DOC | ||||||||
| ONESOURCEOnesource Specialty Pharma Ltd. | UNSTATED | 1,280 | 836–1,280 | 10.1% | — | FY26 | EST | 70% |
| “Member of the Board since: February 27, 2025 Board Memberships 1 Dr. Reddy’s Laboratories Limited 2 M S Pharma International AG 3 Orifarm Group AS 4 Dr. Reddy’…” AR DOC | ||||||||
| VIJAYAVijaya Diagnostic Centre Ltd. | UNSTATED | 733 | 479–733 | 5.8% | — | FY26 | EST | 75% |
| “Mr. Chavali has previously served as the CEO of Aurigene Discovery Technologies Limited and has held significant positions at Dr. Reddy’s Laboratories Limited.” AR · +1 DOC | ||||||||
| TATACONSUMTata Consumer Products Ltd. | UNSTATED | — | — | — | — | FY26 | EST | 75% |
| “Ms. Sharma also serves on the Board of Directors for several companies, including Tech Mahindra Limited, Mahindra & Mahindra Limited, Dr. Reddy’s Laboratories …” AR · +1 DOC | ||||||||
| FRACTALFractal Analytics Ltd. | UNSTATED | — | — | — | — | FY26 | EST | 75% |
| “He serves as the Chairperson of NASSCOM and as an Independent Director at Ideaforge, NIIT and Dr. Reddy's Laboratories and as Nominee Director of NASSCOM on th…” AR DOC | ||||||||
| MANKINDMankind Pharma Ltd. | UNSTATED | — | — | — | R&D | FY25 | EST | 75% |
| “Takeda – Vonoprazan Partnered with Innovent Biologics to commercialise Sintilimab in India Acquired brands of Panacea Biotec Pharma Limited enabling entry into…” AR DOC | ||||||||
| Renewable Energy | UNSTATED | — | — | — | SG&A | FY26 | EST | 70% |
| “A supplier sustainability maturity assessment framework evaluates significant suppliers covering 60% of procurement spend against defined environmental require…” AR DOC | ||||||||
| China. | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “D. Enhancing trust with our stakeholders Compliance, Ethics, and Corporate governance: • Meet the highest standards on compliance and ethics backed by robust c…” AR · +1 DOC | ||||||||
| Others | UNSTATED | — | — | — | — | FY26 | EST | 70% |
| “Restricted cash balances included above Balance in unclaimed dividend account 80 87 Other restricted cash balances 70 70 2.6 F. Other bank balances Particulars…” AR · +1 DOC | ||||||||
| Others | UNSTATED | — | — | — | COGS | FY26 | EST | 70% |
| “(3) Others primarily includes advances given to other vendors, employees 280 281Integrated Annual ReportFY 2024-25 Corporate Overview Strategic Review Statutor…” AR · +1 DOC | ||||||||
| NESTLEINDNestle India Ltd. | UNSTATED | — | — | — | — | FY25 | EST | 70% |
| “Reduction in sugar ~10,000 Distributors associated with Nestlé for more than 10 years Distributors and re-distributors ~4,600Suppliers40% Partnerships Personal…” AR DOC | ||||||||
| SOURCE | READ | % | LAST READ |
|---|---|---|---|
| ANNUAL | 2/2 | 100% | 15-OCT-26 |
| CONCALL | 5/5 | 100% | 08-NOV-26 |
| SCREENER | 1/1 | 100% | 08-NOV-26 |
| SIGNAL | VALUE | AS OF | INPUTS |
|---|---|---|---|
| CUSTOMER HHI | 0.499 | 14-NOV-26 | Action Construction Equipment Ltd. share 50% · Central Depository Services (India) Ltd. share 0% · Syngene International Ltd. share 50% |
| CUST MOM 1M | +8.9% | 14-NOV-26 | from 15-OCT-26 · Action Construction Equipment Ltd. +2.1% w 0 · Central Depository Services (India) Ltd. +11.9% w 0 · Syngene International Ltd. +15.6% w 1 |
| DISTRESS SCORE | 0.200 | 13-OCT-26 | roe 0.11 · operatingMargin 0.19 · debtToEquity 0.2 · interestCoverage 15.42 · assetTurnover 0.6 · leverage 1.49 |
| SUPP MOM 1M | +3.9% | 14-NOV-26 | from 15-OCT-26 · Fortis Healthcare Ltd. +2.4% w 1 · Tata Consumer Products Ltd. +8.8% w 0 · Neuland Laboratories Ltd. +5.6% w 0 · Onesource Specialty Pharma Ltd. +12.3% w 0 · Vijaya Diagnostic Centre Ltd. +1.6% w 0 · Fractal Analytics Ltd. +13.4% w 0 |